Omnium News
Partially corroboratedLive story

Is the updated COVID vaccine still “worth it”? What the 2025–26 evidence shows

We are fairly confident the updated 2025–26 COVID vaccine meaningfully reduces hospitalization and urgent care for adults — most clearly for older and higher-risk people.

Where the claims stand

1 corroborated3 supported

Six years into the pandemic, most people have immunity from prior infection, vaccination, or both — so the real question is what the latest booster adds on top of that. New 2026 studies converge on a meaningful but modest reduction in hospitalization and urgent care, largest for older and higher-risk adults, and waning over months. Whether it’s “worth it” depends a lot on who you are.

Sign in to follow

We'll only notify you when something material changes.

Additional information

Status

as of June 26, 2026
Partially corroborated

The scientific evidence is fairly consistent on benefit; the public and political debate is heated, and the magnitude — and personal value — depends on age and risk. A March 2026 episode in which a CDC effectiveness analysis was held from MMWR — later published in JAMA Network Open — remains part of the process story: officials cited methodological concerns; critics argued the hold was about results, not methods. We read this at the claim level, not as a yes/no verdict on “worth it,” and we do not treat motive as an established fact.

Confidence — current state

Multiple 2026 test-negative studies, including one in JAMA Network Open, converge on roughly 50–55% reductions in the months after vaccination, with protection waning over time. How “worth it” it is for any individual depends heavily on age and underlying risk; the largest absolute benefits are in adults 65+ and those with chronic conditions.

This is our best read given the published evidence we have reviewed — not a claim of absolute truth.

Open questions

  • How large is the absolute benefit for healthy younger adults?

    Relative reductions can look big while the absolute risk reduction for low-risk people is small — which changes the personal cost/benefit.

  • How durable is protection against newer, heavily mutated variants?

    A new variant was detected in many states in early 2026, and effectiveness wanes within months of each dose.

  • How much does vaccination reduce long COVID?

    Observational studies suggest an association, but this is harder to establish than protection against acute hospitalization.

What would change our mind

  • Rigorous data showing no net benefit — or harms outweighing benefits — in a specific group.
  • Replicated evidence that the test-negative study design materially overstated effectiveness.

Claims & evidence

Each claim is tracked separately — not a single verdict.

What this doesn’t establish

Claims commonly associated with this story that the available evidence does not establish. Confirming a narrow fact here is not confirmation of the broader narrative around it. As such, these claims are not included in the claims bar above.

  • The cardiovascular benefit extends to a “hidden burden” of undetected COVID infections.

    Unverified
    Evidence basisPeer-reviewed · single source
    • Peer-reviewedJune 24, 2026
      Authors’ interpretation of the all-cause cardiovascular reduction

      “The substantially larger reduction in all-cause MACE suggests that the vaccine’s protective association extends to the hidden burden of undetected SARS-CoV-2” — an inference, not a direct measurement.

How we got here

4 updates · append-only
  1. New evidence

    The blocked study is published in JAMA Network Open — and two more studies land

    The effectiveness study held from MMWR is published in peer-reviewed JAMA Network Open, with an accompanying commentary defending the test-negative method. It estimates ~55% protection against hospitalization and ~50% against urgent care in immunocompetent adults. Separately, a VA study ties updated vaccination to fewer cardiovascular events in older adults, and a commentary argues the benefit-risk balance favors vaccination. Later reporting (including in The BMJ) recounts the March hold and the disputed explanations for it.

    What changed

    • Claim: updated booster reduces hospitalization: unverified corroborated (multiple 2026 studies)
    • Status: contested partially-corroborated
  2. New evidence

    Manufacturer-funded preprint finds protection in adults 65+

    A Moderna-funded medRxiv preprint (Vicic et al.) reports absolute vaccine effectiveness for 2025–26 mRNA vaccines against COVID-related hospitalization of roughly 48–59% in adults ≥65, with medically attended COVID-19 reduced by about 41–42%. It is not peer-reviewed and comes from a vaccine manufacturer’s research group — useful corroboration of magnitude in older adults, not a standalone verdict.

    What changed

    • Evidence: older-adult hospitalization protection: Awaiting published 2025–26 effectiveness estimates Preprint reports ~48–59% VE against hospitalization in ≥65
  3. Correction

    A CDC effectiveness study is held back from the agency’s own journal

    A CDC-linked effectiveness analysis (Wiegand et al.), originally slated for MMWR after clearance through the agency’s Office of Science, is held from publication by acting CDC director Jay Bhattacharya. Officials cite methodological concerns about the test-negative design; Bhattacharya later defends that rationale publicly. Critics — including some epidemiologists quoted in later coverage — argue the method is standard and that the hold looks results-driven. Living News records the publication dispute and the competing explanations; it does not treat political motive as established.

    What changed

    • Status: developing contested
  4. New evidence

    An updated, JN.1-targeted booster becomes available for 2025–26

    The reformulated 2025–26 COVID vaccine — targeting the Omicron JN.1 lineage and its descendants — becomes available in September 2025. The open question at the time: how much protection does it add for a population that already has substantial immunity from prior infection and vaccination?

    What changed

    • Question on record: — What does the updated booster add on top of existing immunity?

Suggest a source

Point us to a primary source or a publisher correction. Sign in to submit — every suggestion is reviewed by a human before anything changes.

Confidence last reviewed June 26, 2026. Updates are append-only; nothing here is edited silently.